Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 216,835,552
  • Shares Outstanding, K 959,025
  • Annual Sales, $ 24,540 M
  • Annual Income, $ 6,194 M
  • 60-Month Beta 0.24
  • Price/Sales 8.76
  • Price/Cash Flow 25.04
  • Price/Book 31.55
Trade LLY with:

Options Overview

Details
  • Implied Volatility 23.27%
  • Historical Volatility 40.45%
  • IV Percentile 2%
  • IV Rank 4.46%
  • IV High 44.72% on 03/12/21
  • IV Low 22.27% on 04/29/21
  • Put/Call Vol Ratio 1.13
  • Today's Volume 3,503
  • Volume Avg (30-Day) 16,491
  • Put/Call OI Ratio 1.19
  • Today's Open Interest 229,042
  • Open Int (30-Day) 194,390

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 1.90
  • Number of Estimates 3
  • High Estimate 2.05
  • Low Estimate 1.77
  • Prior Year 1.89
  • Growth Rate Est. (year over year) +0.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
193.11 +15.75%
on 05/19/21
235.85 -5.23%
on 06/10/21
+27.31 (+13.92%)
since 05/14/21
3-Month
178.58 +25.17%
on 04/28/21
235.85 -5.23%
on 06/10/21
+34.36 (+18.16%)
since 03/15/21
52-Week
129.21 +72.99%
on 10/30/20
235.85 -5.23%
on 06/10/21
+82.00 (+57.94%)
since 06/15/20

Most Recent Stories

More News
Cocrystal's (COCP) Antiviral CDI-45205 Effective Against COVID-19

Cocrystal (COCP) SARS-CoV-2 3CL protease inhibitor, CDI-45205, found to be effective in treating the original and two other variants of the COVID-19 virus. Shares up.

REGN : 527.49 (-0.24%)
LLY : 223.52 (-1.14%)
GILD : 68.09 (-0.09%)
COCP : 1.2900 (-5.84%)
Lilly Announces Head-to-Head Study Comparing Once-Monthly Emgality® with Every-Other-Day Nurtec® ODT for the Preventive Treatment of Migraine

/PRNewswire/ --To advance the science of migraine treatment and aid the understanding of calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) compared to oral CGRP receptor antagonists in...

LLY : 223.52 (-1.14%)
Lilly announces new clinical data from Verzenio and oral SERD programs at the American Society of Clinical Oncology annual meeting

COMTEX_388270230/2669/2021-06-14T16:15:35

LLY : 223.52 (-1.14%)
LOXO : 234.80 (+0.06%)
Lilly to Participate in Guggenheim Biopharma Strategy Series

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Biopharma Strategy Series – Biopharma's Next Decade: Views from the Top on Global Strategy and Innovation – on...

LLY : 223.52 (-1.14%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 74.36 (-0.07%)
JNJ : 164.49 (-0.53%)
LLY : 223.52 (-1.14%)
CTLT : 108.47 (-1.01%)
PJP : 80.92 (-0.49%)
IHE : 186.92 (-0.31%)
Increasing Prevalence of Acute Otitis Media to Drive Acute Otitis Media Therapeutics Market Growth

Research Nester released a report titled which delivers detailed overview of the global acute otitis media therapeutics market in terms of market segmentation by drug type, formulation, distribution channel...

BAYRY : 16.2950 (+0.46%)
NVS : 93.91 (+0.34%)
PDP.VN : 0.300 (+1.69%)
PFE : 39.59 (-0.10%)
BAYN : 0.0100 (unch)
NOVN : 15.28 (-11.93%)
LLY : 223.52 (-1.14%)
GSK : 40.57 (+0.20%)
MDP : 41.90 (-0.14%)
SAN : 4.21 (unch)
ABT : 110.41 (-0.06%)
Lilly Announces Webcast to Provide Diabetes Portfolio Update at ADA

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will host a webcast on to discuss the company's diabetes portfolio and its presentations at the American Diabetes Association's Virtual 81st Scientific...

LLY : 223.52 (-1.14%)
Thinking about trading options or stock in Crispr Therapeutics, AMC, Atomera, Prothena Corp, or Eli Lilly?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CRSP, AMC, ATOM, PRTA, and LLY.

CRSP : 123.62 (-3.99%)
PRTA : 51.97 (+9.07%)
ATOM : 25.42 (-4.22%)
AMC : 59.04 (+3.58%)
LLY : 223.52 (-1.14%)
Pharma Stock Roundup: FDA Approval for NVO, PFE Products & Other Updates

FDA approves Novo Nordisk's (NVO) obesity treatment, Wegovy and Pfizer's (PFE) 20-valent pneumococcal conjugate vaccine, Prevnar 20.

NVS : 93.91 (+0.34%)
PFE : 39.59 (-0.10%)
NVO : 84.57 (+0.17%)
MRK : 75.70 (+0.33%)
LLY : 223.52 (-1.14%)
BNTX : 218.17 (-1.09%)
Thinking about trading options or stock in Eli Lilly, Pfizer, GameStop, Cleveland-Cliffs, or FuelCell Energy?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LLY, PFE, GME, CLF, and FCEL.

FCEL : 9.21 (-4.86%)
CLF : 22.86 (+3.25%)
GME : 222.50 (-3.02%)
LLY : 223.52 (-1.14%)
PFE : 39.59 (-0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their...

See More

Key Turning Points

3rd Resistance Point 229.62
2nd Resistance Point 228.14
1st Resistance Point 225.83
Last Price 223.52
1st Support Level 222.04
2nd Support Level 220.56
3rd Support Level 218.25

See More

52-Week High 235.85
Last Price 223.52
Fibonacci 61.8% 195.11
Fibonacci 50% 182.53
Fibonacci 38.2% 169.95
52-Week Low 129.21

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar